New insights into the biology and development of lung cancer in never smokers—implications for early detection and treatment
Abstract Lung cancer is the leading cause of cancer deaths worldwide. Despite never smokers comprising between 10 and 25% of all cases, lung cancer in never smokers (LCNS) is relatively under characterized from an etiological and biological perspective. The application of multi-omics techniques on l...
Main Authors: | Peiyao Wang, Sophie Sun, Stephen Lam, William W. Lockwood |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-08-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-023-04430-x |
Similar Items
-
Alpha-1 antitrypsin deficiency and risk of lung cancer in never-smokers: a multicentre case–control study
by: Ramón Antonio Tubío-Pérez, et al.
Published: (2022-01-01) -
The association of BTLA gene polymorphisms with non-small lung cancer risk in smokers and never-smokers
by: Anna Andrzejczak, et al.
Published: (2023-01-01) -
Non-small cell lung cancer in never smokers: a clinical entity to be identified
by: Ilka Lopes Santoro, et al.
Published: (2011-01-01) -
Implications of the Immune Landscape in COPD and Lung Cancer: Smoking Versus Other Causes
by: Elisabeth Taucher, et al.
Published: (2022-03-01) -
Improved Prognostic Prediction in Never-Smoker Lung Cancer Patients by Integration of a Systemic Inflammation Marker with Tumor Immune Contexture Analysis
by: Massimo Milione, et al.
Published: (2020-07-01)